NextPlat (NXPL) Capital Expenditures (2015 - 2026)
NextPlat's (NXPL) quarterly Capital Expenditures came in at $53000.0 in Q2 2026, down 15.87% year-over-year from $63000.0 in Q2 2025, and up 200.0% quarter-over-quarter from -$53000.0 in Q1 2026.
Analysis
NextPlat (NXPL) Capital Expenditures (2015 - 2026) Analysis & Trends
NextPlat (NXPL) has reported Capital Expenditures for 12 consecutive years, with $53000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Capital Expenditures fell 15.87% year-over-year to $53000.0 in Q2 2026; TTM through Jun 2026 was $37000.0, a 62.63% decrease from a year earlier, with the FY2025 full-year figure at $71000.0, down 62.43% from the prior year.
- Capital Expenditures was $53000.0 for Q2 2026 at NextPlat, up from -$53000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $355000.0 in Q3 2023 and troughed at -$53000.0 in Q1 2026.
- A 5-year average of $95470.6 and a median of $64000.0 in 2024 frame the typical range for Capital Expenditures.
- Across the five-year window, Capital Expenditures jumped 14714.16% in 2022 and sank 145.31% in 2025, its largest moves.
- Over 5 years, Capital Expenditures stood at $244882.0 in 2022, then retreated by 22.82% to $189000.0 in 2023, then tumbled by 116.93% to -$32000.0 in 2024, then surged by 215.62% to $37000.0 in 2025, then jumped by 43.24% to $53000.0 in 2026.
- The last three Capital Expenditures figures came in at $53000.0 (Q2 2026), -$53000.0 (Q1 2026), and $37000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 104.00 Mn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 52.80 Mn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | -36.19 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 30.70 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 77.00 Mn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 3.05 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | -27.87 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 8.59 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | - |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn | 53,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 53,000.00 |
| Mar 31, 2026 | -53,000.00 |
| Dec 31, 2025 | 37,000.00 |
| Jun 30, 2025 | 63,000.00 |
| Mar 31, 2025 | -29,000.00 |
| Dec 31, 2024 | -32,000.00 |
| Sep 30, 2024 | 97,000.00 |
| Jun 30, 2024 | 60,000.00 |
| Mar 31, 2024 | 64,000.00 |
| Dec 31, 2023 | 189,000.00 |
| Sep 30, 2023 | 355,000.00 |
| Jun 30, 2023 | 34,000.00 |
| Mar 31, 2023 | 69,000.00 |
| Dec 31, 2022 | 244,882.00 |
| Sep 30, 2022 | 75,873.00 |
| Jun 30, 2022 | 327,248.00 |
| Mar 31, 2022 | 67,997.00 |
| Dec 31, 2021 | 133,709.00 |
| Sep 30, 2021 | 68,350.00 |
| Jun 30, 2021 | 26,789.00 |